Exchange: NASDAQ·Updated 07:16 PM EDT
PLRX logo

PLRX Pliant Therapeutics Inc

$1.07
$0.02
(2.00%)
Today
Closed $1.02
$0.054
(5.29%)
After Hours
EarningsNov 12
Mkt Cap$63.16M
Vol288,527.00

About PLRX

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
56

Bullish Sentiment

How do you feel about PLRX?

THSSKS
$PLRX this will never run with the huge Leerink ATM and shelf in place. Management had a chance to sell this dung over the last two years but chose to burn all the cash, enrich themselves and chase a dog chit pipeline.
1
THSSKS
$PLRX doubt this junk will ever run with a trash pipeline, 2 poison pills and a $300M shelf and ATM in place.
M31V1
$PLRX Cash rich with PLN-101095 essentially being the main value driver. The key catalyst is the 2027 FORTIFY readout, until then, potentially trades sideways.

Advertisement|Remove ads.